Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01282164 · ClinicalTrials.gov registry record · NA
The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis
A NA study of Adult Growth Hormone Deficiency and Hypothalamic-pituitary Disorders, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 4
- Study locations
NCT01282164 is a NA study of Adult Growth Hormone Deficiency and Hypothalamic-pituitary Disorders that has completed, run by The Cleveland Clinic. The registered enrollment target is 43 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT01282164, a NA study of Adult Growth Hormone Deficiency and Hypothalamic-pituitary Disorders, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to find out if the Glucagon Stimulation Test (GST) is a reliable alternative to the Insulin Tolerance Test (ITT) for diagnosis of Growth Hormone Deficiency (GHD) and adrenal insufficiency. In some patients the accuracy of the GST for evaluation of adrenal insufficiency is compared to the adrenocorticotropin hormone (ACTH ) stimulation test.
Conditions Studied
Interventions
- PROCEDURE Glucagon stimulation test and insulin tolerance test
- PROCEDURE glucagon stimulation test and insulin tolerance test
Study Locations (4)
Massachusetts
- Massachusetts General Hospital - Boston
Ohio
- Cleveland Clinic Endocrinology, Diabetes and Metabolism - Cleveland
Oregon
- Oregon Health and Sciences University - Portland
Pennsylvania
- Allegheny Endocrinology Associates - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01282164
The ClinicalTrials.gov registry entry for NCT01282164 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Adult Growth Hormone Deficiency appearing as the primary indexed condition, and to 2 interventions - of which Glucagon stimulation test and insulin tolerance test is the first listed.
NCT01282164 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, Ohio, Oregon.
Frequently Asked Questions
What is clinical trial NCT01282164 about?
NCT01282164 is a clinical study titled "The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis". The purpose of this study is to find out if the Glucagon Stimulation Test (GST) is a reliable alternative to the Insulin Tolerance Test (ITT) for diagnosis of Growth Hormone Deficiency (GHD) and adrenal insufficiency. In some patients the accuracy of the GST for evaluation of adrenal insufficiency i...
What is the current status of trial NCT01282164?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2011-01. Estimated completion is 2014-07.
What conditions does trial NCT01282164 study?
This clinical trial studies the following conditions: Adult Growth Hormone Deficiency, Hypothalamic-pituitary Disorders.
What interventions are being tested in trial NCT01282164?
The interventions under investigation include: Glucagon stimulation test and insulin tolerance test (PROCEDURE), glucagon stimulation test and insulin tolerance test (PROCEDURE).
Who is sponsoring clinical trial NCT01282164?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01282164 being conducted?
This trial has 4 study locations across Massachusetts, Ohio, Oregon, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adult Growth Hormone Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Adult Growth Hormone Deficiency
All registered trials for this condition
Hypothalamic-pituitary Disorders
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.